Benebiose SRL
Benebiose reported total assets of 2,966 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Benebiose shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -97 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Benebiose's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 14 May 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
Benebiose's financial analysis
- Solvency-277.6%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Benebiose
Benebiose's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0784.521.548
- VAT number
- BE0784521548
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 05 Apr 2022
- Registered office
- 9052 Ghent
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Benebiose (SRL) has been based in Ghent since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 566 € and equity of −8,232 €; its revenue is not published. Its solvency stands at -277.6%, below the median of its sector (60.4%).
Companies similar to Benebiose
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- ArrowBiome Europe Research and experimental development on natural sciences and engineering Antwerp · balance sheet 2,918 €
- Levels Diagnostics Belgium Research and experimental development on natural sciences and engineering Antwerp · balance sheet 715 €
- Eurimmaux Research and experimental development on natural sciences and engineering Jette · balance sheet 43,305 €
- Bridging FOR Sustainability Research and experimental development on natural sciences and engineering Clavier · balance sheet 44,057 €
- LivingMed Biotech Research and experimental development on natural sciences and engineering Marche-en-Famenne · balance sheet 51,717 €
- NCD Consultants Research and experimental development on natural sciences and engineering Overijse · balance sheet 55,512 €
- Sealantium Medical Belgium Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 56,033 €
Frequently asked questions about Benebiose
What is the revenue of Benebiose?
Benebiose files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Benebiose?
In Belgium, the VAT number is the company number prefixed with BE: BE0784521548 for Benebiose, if the company is VAT-registered. Its company number (CBE) is 0784.521.548.
Where is the registered office of Benebiose?
According to the CBE register, the registered office of Benebiose is in 9052 Ghent.
What is the equity of Benebiose?
At the close of the 2025 financial year, the equity of Benebiose amounts to -8,232 €, a solvency of -277.6% of total assets.
Who manages Benebiose?
The register lists 6 active mandates at Benebiose. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Benebiose
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →